Kasumi B. Yamamoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Real-world efficacy and safety of cemiplimab in Japanese patients with recurrent or metastatic cervical cancer: A single-center retrospective cohort study.
Journal: Gynecologic oncology reports
Published: June 14, 2026
The efficacy and safety of lenvatinib plus pembrolizumab therapy in patients with uterine carcinosarcoma.
Journal: Gynecologic oncology reports
Published: June 27, 2024
Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.
Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: June 24, 2024
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.
Journal: Anticancer research
Published: March 01, 2024
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
Journal: Virchows Archiv : an international journal of pathology
Published: May 19, 2023
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
Journal: Journal of gynecologic oncology
Published: May 09, 2023
Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection.
Journal: Annals of diagnostic pathology
Published: March 31, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
Journal: Frontiers in oncology
Published: February 03, 2023
Delayed-onset contact dermatitis caused by olanexidine gluconate antiseptic solution: effect of wiping off the remaining drug solution in two cases.
Journal: JA clinical reports
Published: January 29, 2023
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.
Journal: Scientific reports
Published: December 20, 2022
Changes in HER3 expression profiles between primary and recurrent gynecological cancers.
Journal: Cancer cell international
Published: October 30, 2022
Last Updated: 09/26/2026